Clin2
NCT07137312Possibly a fitRecruiting

Growing immune cells outside the body to fight cancer

Solid TumorHealthyMalignant Solid Neoplasm

Treatments studied

Part of Cancer clinical trials.

This trial tests a new way to take blood from patients with solid tumors or healthy volunteers, grow immune cells in a lab, and then give them back to potentially treat cancer. It may help people whose standard options have run out.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
24 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have had a solid tumor cancer or you are a healthy person.
  • You are willing to give a blood sample or have your blood filtered through a machine (apheresis).
  • Your blood counts (hemoglobin, white cells, platelets) are above certain levels.
  • You haven't had IV antibiotics in the last 2 weeks or major surgery in the last 4 weeks.
  • You don't have HIV, active hepatitis B or C, or active tuberculosis.
  • You aren't taking high-dose steroids or other drugs for an autoimmune disease.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05831033Recruiting· Early Phase 1
Your own immune T-cells to treat advanced solid tumors

This early-phase study tests a treatment made from your own tumor-fighting immune cells (TIL cells) for advanced solid cancers that have worsened or no longer respond to standard therapy. The main goal is to learn whether it is safe and whether it can shrink tumors for people who have limited options.

Shanghai, Shanghai Municipality
NCT05354765Recruiting
Collect immune cells by lymphapheresis to study cancer response

This trial studies how changing your immune system (with earlier treatments) affects cancer by collecting immune cells from your blood using a process called lymphapheresis. It may help researchers find better ways to monitor immune-related responses and side effects.

Paris
NCT02682667Recruiting
Providing blood samples for cancer immunotherapy research

This study collects and stores blood/tissue samples (called biospecimens) to support immunotherapy research at the cancer center. If you may qualify, your samples help researchers test new immune-based cancer treatments.

Bethesda, Maryland
NCT06131775Recruiting
Study of immune cells in blood of people with solid tumors

This study is looking at a specific type of immune cell (called TLR4+ cells) in the blood of people with solid tumors. By studying these cells, researchers hope to learn more about how the immune system reacts to cancer and to treatments.

Bron
NCT07260058Not yet recruiting· Phase 1/Phase 2
Immune cell therapy for advanced solid tumors

This trial tests a new immune cell therapy for people with advanced solid tumors (lung, liver, colorectal, or breast cancer). It aims to use your own immune cells to fight the cancer, and might help if standard treatments have stopped working.

NCT00571389Recruiting
Collecting blood cells from people with cancer or COVID-19

This study collects blood cells using a special blood-draw procedure called leukapheresis (for some participants) and other samples. It aims to better understand cancer and immune-related cells, which may help researchers design or improve future treatments.

Huntersville, North Carolina

Hear when a new Solid Tumor trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.